Navigation Links
Extending the vase life of cut flowers: Pre-treatments and preservatives studied
Date:7/1/2011

RALEIGH, NCEach year, a wide variety of new cut flower cultivars and species are evaluated in trials administered by North Carolina State University and the Association of Specialty Cut Flower Growers. The research, conducted at about 50 locations in the United States and Canada, provides valuable production and marketing information.

John M. Dole and a research team from North Carolina State University undertook a multiyear study designed to identify patterns of postharvest responses to commercial hydrator and holding floral preservatives among 121 cultivars from 47 genera. The team chose stems of "promising and productive cultivars" from the National Trial Program, pretreated them with either a commercial hydrating solution or deionized (DI) water, then placed them in either a commercial holding solution or DI water. The results of the comprehensive 8-year study premiered in HortTechnology.

According to Dole, although there was cultivar variation within each genus, patterns of postharvest responses emerged during the study. The largest response category was one in which the vase life of 53 cultivars was increased by treating with a holding preservative. Consumer favorites in this category include: basil, bee balm, blackeyed susan, coneflower, coral bells, foxglove, lisianthus, ornamental pepper, shasta daisy, sunflower, snapdragon, and zinnia, among others.

Interestingly, the researchers determined that holding preservatives actually reduced the vase life of 14 cultivars such as ageratum, false queen anne's lace, lisianthus, pineapple lily, yarrow, and zinnia. Hydrating preservatives reduced the vase life of 18 cultivars, including feverfew, lisianthus, ornamental pepper, pineapple lily, shasta daisy, sweet william, sunflower, yarrow, and zinnia. Application of a combination treatment showed that the use of hydrating and holding preservatives reduced vase life in 12 cultivars.

The researchers concluded that, f
'/>"/>

Contact: Michael W. Neff
mwneff@ashs.org
703-836-4606
American Society for Horticultural Science
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Scientists locate oil plume extending toward Dry Tortugas
2. Novel processing technologies developed for extending use of oats in gluten-free diet
3. Extending the life of fresh cranberries
4. Longer-lasting flowers: Fresh ideas from ARS researchers
5. New technique can fast-track better ionic liquids for biomass pre-treatments
6. Mescal worm test shows DNA leaks into preservatives
7. Probing and controlling molecular rattling may mean better preservatives
8. Potential impact of cinnamon on multiple sclerosis studied
9. Umbilical cord blood-derived stem cells studied for lupus therapy
10. Landscape tree disease from 12 wood decay fungi studied
11. Golden eagles studied by satellite
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Extending the vase life of cut flowers: Pre-treatments and preservatives studied
(Date:7/31/2015)... Chine, 31 juillet 2015 La 10e ... ) sera organisée par le BGI du 22 ... en Chine. La conférence ... inauguration en 2006, l,ICG est devenue l,une des ... domaine des « omiques » et c,est aussi la plus ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/21/2015)... -- Today, ZTE announced its Android smartphone Axon, featuring ... revenues in 2015 that relate to sales of FPC1025 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... China and we are proud that ... Axon , its first ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... preference for speech through in-utero eavesdropping, or is their ... test, but one that's central to understanding the origins ... a McGill University psychologist believes she's separated out the ... results, says Dr. Athena Vouloumanos, point to a genetic ...
... University of Pennsylvania School of Medicine discovered that a ... internal molecular clock in mammals. What's more, this molecule ... light on circadian rhythm disorders, including bipolar disorder. The ... metabolism, are reported in this week's issue of Science. ...
... Scientists supported by the National Institute of Allergy and ... Health (NIH), have identified a defect in the immune ... that puts them at risk of developing serious complications ... Ph.D., of the National Jewish Medical and Research Center ...
Cached Biology News:Born with a love of speech 2Born with a love of speech 3Clock molecule's sensitivity to lithium sheds light on bipolar disorder 2Defective immune system response to smallpox vaccine detailed in new study 2Defective immune system response to smallpox vaccine detailed in new study 3
(Date:7/30/2015)... 2015 AACC welcomed thousands of medical ... Annual Meeting & Clinical Lab Expo in ... meeting showcased revolutionary advancements in clinical testing technology ... providers to diagnose patients quickly and accurately and ... As of Wednesday, July 29, more ...
(Date:7/30/2015)... Texas (PRWEB) , ... July 30, 2015 , ... The ... and in-depth study on the current state of the global Propanol market with a ... Sinopec, CNPC, BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch ...
(Date:7/30/2015)... 2015   Aratana Therapeutics, Inc . (NASDAQ: ... on the licensing, development and commercialization of innovative ... its strategic partner VetStem Biopharma, Inc. has shared ... AT-016, an adipose-derived allogeneic stem cell product exclusively ... pain in dogs. The double-blinded, multi-site, ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... discovery that low-intensity, pulsed ultrasound can be used ... for engineering rapid-response medical devices. The team that ... an assistant professor with the Virginia Tech Carilion ... detailing this approach, which may one day lead ...
... Sept. 8, 2011 Enterologics, Inc  ( ... acquisition of The BioBalance Corporation and its subsidiary BioBalance ... this purchase Enterologics acquired its first probiotic biotherapeutic product, ... coli M17 has an active Investigational New Drug ...
... Seeds, an investment firm dedicated to achieving above market ... announced today that it has opened an office at ... support the growing number of investments the firm has ... its first Pittsburgh investment in 2006 in Redpath Pathologies, ...
Cached Biology Technology:Neuroscientists produce guide for ultrasound use to treat brain disorders in clinical emergencies 2Neuroscientists produce guide for ultrasound use to treat brain disorders in clinical emergencies 3Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc 2Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc 3Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc 4Golden Seeds Opens Office in PLSG Incubator 2Golden Seeds Opens Office in PLSG Incubator 3
... The H2OBIT™ is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
... licensed, high throughput, water bath thermal cycler capable ... microplates. This equates to 9,216 reactions per run ... rapidly transfers a basket of plates between three ... are considerably faster than those of peltier block ...
... is a 27kDa periplasmic enzyme from E. ... to cyclic nucleotide monophosphate (NMP) intermediates. Slower ... intermediates to 3-NMPs (1). RNase ONE Ribonuclease ... that can cleave a phosophodiester bond between ...
... Dideoxycytidine is a cytidine analog that has been ... Immunogen: Chemical / Small Molecule ... specificity of the ddC antiserum was determined by ... to moles of ddC analog at the 50% ...
Biology Products: